Sars Virus Spike Protein Recombinant
Lab Reagents
Human IgG antibody Laboratories manufactures the sars virus spike protein recombinant reagents distributed by Genprice. The Sars Virus Spike Protein Recombinant reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Recombinant. Other Sars products are available in stock. Specificity: Sars Category: Virus Group: Spike Protein
SARS-CoV Spike Antibody |
|||
| 3221-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS-CoV Spike Antibody |
|||
| 3221-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS (IN1) Spike Peptide |
|||
| 3221P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (IN) SARS (IN1) Spike peptide |
|||
SARS-CoV Spike Antibody |
|||
| 3223-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS-CoV Spike Antibody |
|||
| 3223-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS (IN2) Spike Peptide |
|||
| 3223P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (IN) SARS (IN2) Spike peptide |
|||
SARS-CoV Spike Antibody |
|||
| 3225-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS-CoV Spike Antibody |
|||
| 3225-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS (IN3) Spike Peptide |
|||
| 3225P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (IN) SARS (IN3) Spike peptide |
|||
SARS Coronavirus Spike Mosaic Recombinant protein (Center) |
|||
| 39-122 | ProSci | 0.1 mg | EUR 556.8 |
|
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies. |
|||
SARS Coronavirus spike (HSZ-Cc) Recombinant Protein |
|||
| 20-219 | ProSci | 0.1 mg | EUR 726.9 |
|
Description: SARS Coronavirus spike (HSZ-Cc) Recombinant Protein |
|||
Recombinant Coronavirus Spike Protein (SARS-CoV S2) |
|||
| P1519-10 | Biovision | 10µg | EUR 187.2 |
Recombinant Coronavirus Spike Protein (SARS-CoV S2) |
|||
| P1519-50 | Biovision | 50µg | EUR 661.2 |
Recombinant SARS Coronavirus Spike, GST-Tagged |
|||
| DAG534 | Creative Diagnostics | 1mg | EUR 1867.2 |
Recombinant 2019-nCoV coronavirus Spike protein, S1 subunit, expressed in Baculovirus-Insect cells |
|||
| Spike-195V | Creative BioMart | 100ug | EUR 1932 |
|
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity. |
|||
Recombinant 2019-nCoV coronavirus Spike protein, S2 ECD, expressed in Baculovirus-Insect cells |
|||
| Spike-197V | Creative BioMart | 100ug | EUR 1932 |
|
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein (S2 ECD) was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity. |
|||
Sars-Cov, Spike (Middle) Recom Protein |
|||
| abx060656-1mg | Abbexa | 1 mg | EUR 2030.4 |